Global Pharmaceuticals & Biotech High Insider Buying

Eli Lilly

Market Cap: US$666.0b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Vertex Pharmaceuticals

Market Cap: US$96.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

GSK

Market Cap: UK£59.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Sino Biopharmaceutical

Market Cap: HK$143.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Summit Therapeutics

Market Cap: US$15.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Viatris

Market Cap: US$11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Avantor

Market Cap: US$8.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

CRISPR Therapeutics

Market Cap: US$5.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Hikma Pharmaceuticals

Market Cap: UK£3.5b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Grand Pharmaceutical Group

Market Cap: HK$29.4b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Zai Lab

Market Cap: US$3.6b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Kalbe Farma

Market Cap: Rp52.9t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Perrigo

Market Cap: US$2.9b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

AddLife

Market Cap: SEK 21.9b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Mesoblast

Market Cap: AU$3.2b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Intellia Therapeutics

Market Cap: US$1.9b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Dyne Therapeutics

Market Cap: US$1.9b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Consun Pharmaceutical Group

Market Cap: HK$13.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Tilray Brands

Market Cap: US$1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Azenta

Market Cap: US$1.4b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Rapport Therapeutics

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Precigen

Market Cap: US$1.2b

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Jacobio Pharmaceuticals Group

Market Cap: HK$7.2b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

Oxford Biomedica

Market Cap: UK£688.6m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Fortrea Holdings

Market Cap: US$859.9m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Kura Oncology

Market Cap: US$727.4m

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Terns Pharmaceuticals

Market Cap: US$688.7m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Gossamer Bio

Market Cap: US$679.9m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

Arvinas

Market Cap: US$567.5m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Swedencare

Market Cap: SEK 5.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Arcturus Therapeutics Holdings

Market Cap: US$555.3m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Zevra Therapeutics

Market Cap: US$502.4m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.